Published in Telemedicine Business Week, September 14th, 2005
"The efficacy of breast cancer screening in the community may differ from that suggested by the results of randomized trials, and no data have been available on efficacy among women who have different levels of breast cancer risk," investigators in the United States observed. "A matched case-control study among women enrolled in six health plans in Washington, Oregon, California, Massachusetts, and Minnesota" was conducted, and "the efficacy of screening by mammography and/or clinical breast examination among women in two age cohorts (40-49 years and 50-65 years) and in two...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Business Week